Lundbeck’s superagonist prompts 61.2% seizure reduction
Results from the open-label extension portion of the Pacific trial saw bexicaserin able to elicit seizure reduction in ...
Lundbeck To Present Positive Pipeline Data At American Academy Of Neurology (AAN) Annual Meeting
VALBY, Denmark, April 4, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition ...
She Feared Her Son's Diagnosis Was a 'Death Sentence' After Endless Seizures. How They're Finding Joy in the Pain (Exclusive)
B was first diagnosed with Lennox-Gastaut syndrome (LGS) due to the frequency and severity of his seizures. He was later ...
Tribune Online on MSN18h
Lagos govt convenes energy summit to tackle 'epileptic' power supply
Lagos State government on Thursday said plans have been concluded to convene an energy summit where a comprehensive strategy and homegrown solutions will be developed by critical stakeholders to ...
WISH-TV19h
Indiana student advocates for epilepsy awareness at Washington, D.C. conference
Raeley Shilling advocates for epilepsy awareness, sharing her personal experience with juvenile absence epilepsy in Plainfield, Indiana.
BMJ Case Reports21h
Neonate with developmental and epileptic encephalopathy 81 (DEE81): lessons learnt and future implications
Developmental and epileptic encephalopathy 81 (DEE81) presents a complex challenge in diagnosis and management due to its rarity and diverse clinical manifestations. Here, we report the case of a ...
Pharmaceutical Technology23h
Neurona raises $102m to advance cell therapy for drug-resistant epilepsy
Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...